Join
Live feed
·
INSIDERFilingvia Quantisnow
Rubius Therapeutics Inc. logo

SEC Form 4: Turka Laurence A. converted options into 16,063 shares and sold $622 worth of shares (2,593 units at $0.24), increasing direct ownership by 274% to 18,391 units to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.
RUBY· Rubius Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RUBY (Rubius Therapeutics Inc.) and more on Quantisnow.

SEC Form 4: Turka Laurence A. converted options into 16,063 shares and sold $622 worth of shares (2,593 units at $0.24), increasing direct ownership by 274% to 18,391 units to satisfy withholding obligation | Quantisnow